The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients

Autoimmunity Reviews

Volumn 15, Issue 12, 2016, Pages 1125-1128

  Fallahi, Poupak ^a   Ferrari, Silvia Martina ^a   Ruffilli, Ilaria ^a   Elia, Giusy ^a   Biricotti, Marco ^a   Vita, Roberto ^b   Benvenga, Salvatore ^b   Antonelli, Alessandro ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

AbTPO; Autoimmune thyroid diseases; Autoimmune thyroiditis; Hypothyroidism; Organ specific autoimmune diseases; Systemic rheumatological disorders

Indexed keywords

ADDISON DISEASE; ADULT; ALOPECIA; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CELIAC DISEASE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GASTRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; PSORIATIC ARTHRITIS; REVIEW; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; VITILIGO; HYPOTHYROIDISM; IMMUNOLOGY; PROSPECTIVE STUDY;

ARTHRITIS, RHEUMATOID; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; PROSPECTIVE STUDIES; THYROIDITIS, AUTOIMMUNE;

EID: 84994494806     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.09.009     Document Type: Review

References (30)

1. [1] Antonelli, A., Ferrari, S.M., Corrado, A., Di Domenicantonio, A., Fallahi, P., Autoimmune thyroid disorders. Autoimmun Rev 14 (2015), 174–180.
2. [2] Miyadera, H., Tokunaga, K., Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism. J Hum Genet 60 (2015), 697–702.
3. [3] Cho, J.H., Feldman, M., Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat Med 21 (2015), 730–738.
4. [4] Robazzi, T.C., Adan, L.F., Autoimmune thyroid disease in patients with rheumatic diseases. Rev Bras Reumatol 52 (2012), 417–430.
5. [5] Cooper, G.S., Stroehla, B.C., The epidemiology of autoimmune diseases. Autoimmun Rev 2 (2003), 119–125.
6. [6] Lu, M.C., Yin, W.Y., Tsai, T.Y., Koo, M., Lai, N.S., Increased risk of primary Sjögren's syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan. PLoS One, 8, 2013, e77210.
7. [7] Milic, V.D., Radunovic, G., Boricic, I., Ognjanovic, S., Petrovic, R., Radak-Perovic, M., et al. High prevalence of autoimmune thyroid disease in subjects with sicca symptoms without Sjogren's syndrome. Rheumatology (Oxford) 52 (2013), 754–755.
8. [8] Antonelli, A., Ferri, C., Fallahi, P., Cazzato, M., Ferrari, S.M., Sebastiani, M., et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 156 (2007), 431–437.
9. [9] Antonelli, A., Fallahi, P., Ferrari, S.M., Mancusi, C., Giuggioli, D., Colaci, M., et al. Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. J Clin Endocrinol Metab 98 (2013), E1198–E1202.
10. [10] Antonelli, A., Ferri, C., Fallahi, P., Ferrari, S.M., Frascerra, S., Carpi, A., et al. Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. Metabolism 57 (2008), 1270–1277.
11. [11] Antonelli, A., Fallahi, P., Mosca, M., Ferrari, S.M., Ruffilli, I., Corti, A., et al. Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism 59 (2010), 896–900.
12. [12] Antonelli, A., Fallahi, P., Delle Sedie, A., Ferrari, S.M., Maccheroni, M., Bombardieri, S., et al. High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. Clin Exp Rheumatol 27 (2009), 22–27.
13. [13] Vitti, P., Rago, T., Mazzeo, S., Brogioni, S., Lampis, M., De Liperi, A., et al. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves’ disease from Hashimoto's thyroiditis. J Endocrinol Invest 18 (1995), 857–861.
14. [14] Cooper, G.S., Bynum, M.L., Somers, E.C., Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33 (2009), 197–207.
15. [15] Barker, J.M., Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 91 (2006), 1210–1217.
16. [16] Laberge, G., Mailloux, C.M., Gowan, K., Holland, P., Bennett, D.C., Fain, P.R., et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 18 (2005), 300–305.
17. [17] Kasperlik-Zaluska, A., Czarnocka, B., Czech, W., High prevalence of thyroid autoimmunity in idiopathic Addison's disease. Autoimmunity 18 (1994), 213–216.
18. [18] Barcellos, L.F., Kamdar, B.B., Ramsay, P.P., DeLoa, C., Lincoln, R.R., Caillier, S., et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 5 (2006), 924–931.
19. [19] Jenkins, R.C., Weetman, A.P., Disease associations with autoimmune thyroid disease. Thyroid 12 (2002), 977–988.
20. [20] Boelaert, K., Newby, P.R., Simmonds, M.J., Holder, R.L., Carr-Smith, J.D., Heward, J.M., et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123 (2010), 183.e1–183.e9.
21. [21] Brix, T.H., Christensen, K., Holm, N.V., Harvald, B., Hegedüs, L., A population-based study of Graves’ disease in Danish twins. Clin Endocrinol (Oxf) 48 (1998), 397–400.
22. [22] Ringold, D.A., Nicoloff, J.T., Kesler, M., Davis, H., Hamilton, A., Mack, T., Further evidente for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid 12 (2002), 647–653.
23. [23] Brix, T.H., Kyvik, K.O., Hegedus, L., A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85 (2000), 536–539.
24. [24] Tomer, Y., Davies, T.F., Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24 (2003), 694–717.
25. [25] Antonelli, A., Ferrari, S.M., Frascerra, S., Pupilli, C., Mancusi, C., Metelli, M.R., et al. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves’ and normal thyrocytes. J Clin Endocrinol Metab 95 (2010), 413–420.
26. [26] Antonelli, A., Fallahi, P., Ferrari, S.M., Pupilli, C., d'Annunzio, G., Lorini, R., et al. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study. Diabet Med 25 (2008), 1349–1353.
27. [27] Zignego, A.L., Enhanced TH1 cytokine production in hepatitis C virus-infected patients with mixed cryoglobulinemia: understanding the pathological issues. J Hepatol 41 (2004), 1045–1049.
28. [28] Antonelli, A., Ferri, C., Fallahi, P., Ferrari, S.M., Frascerra, S., Sebastiani, M., et al. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine 42 (2008), 137–143.
29. [29] Antonelli, A., Fazzi, P., Fallahi, P., Ferrari, S.M., Ferrannini, E., Prevalence of hypothyroidism and Graves disease in sarcoidosis. Chest 130 (2006), 526–532.
30. [30] Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., Romagnani, S., Human Th1 dichotomy: origin, phenotype and biologic activities. Immunology, Oct 5 2014, 10.1111/imm.12399.